Adam Dubow
Chief Compliance & Ethics Offi, Bristol-Myers Squibb.
Companies
- Day One Biopharmaceuticals, Inc.Gen Counsel & Secretary Aug 19, 2025 to now1
- Day One Biopharmaceuticals, Inc.General counsel Nov 16, 2023 to now2
- Bristol-Myers SquibbChief Compliance & Ethics Offi Jun 22, 2018 to Aug 3, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Bristol-Myers Squibb BMY14,749 shares4$880.1K at $59.67Aug 3, 2021- Day One Biopharmaceuticals, Inc.0 shares5Apr 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 23, 2026Returned to company 72,694 shares of Day One Biopharmaceuticals, Inc.5
- Feb 17, 2026Sold 6,395 shares at $11.60 of Day One Biopharmaceuticals, Inc.6
- Feb 15, 2026Exercised options 4,375 shares of Day One Biopharmaceuticals, Inc.6
- Feb 15, 2026Exercised options 3,687 shares of Day One Biopharmaceuticals, Inc.6
- Feb 15, 2026Exercised options 3,688 shares of Day One Biopharmaceuticals, Inc.6
- Feb 15, 2026Exercised options 1,750 shares of Day One Biopharmaceuticals, Inc.6
- Feb 15, 2026Exercised options 2,963 shares of Day One Biopharmaceuticals, Inc.6
- Nov 17, 2025Sold 4,319 shares at $8.91 of Day One Biopharmaceuticals, Inc.7
- Nov 15, 2025Exercised options 3,687 shares of Day One Biopharmaceuticals, Inc.7
- Nov 15, 2025Exercised options 3,687 shares of Day One Biopharmaceuticals, Inc.7
- Nov 15, 2025Exercised options 1,750 shares of Day One Biopharmaceuticals, Inc.7
- Nov 15, 2025Exercised options 2,963 shares of Day One Biopharmaceuticals, Inc.7
- Aug 18, 2025Sold 4,365 shares at $6.77 of Day One Biopharmaceuticals, Inc.8
- Aug 15, 2025Exercised options 3,687 shares of Day One Biopharmaceuticals, Inc.8
- Aug 15, 2025Exercised options 3,687 shares of Day One Biopharmaceuticals, Inc.8
- Aug 15, 2025Exercised options 1,750 shares of Day One Biopharmaceuticals, Inc.8
- Aug 15, 2025Exercised options 2,963 shares of Day One Biopharmaceuticals, Inc.8
- May 16, 2025Sold 4,552 shares at $6.26 of Day One Biopharmaceuticals, Inc.9
- May 15, 2025Exercised options 3,687 shares of Day One Biopharmaceuticals, Inc.9
- May 15, 2025Exercised options 3,687 shares of Day One Biopharmaceuticals, Inc.9
- May 15, 2025Exercised options 1,750 shares of Day One Biopharmaceuticals, Inc.9
- May 15, 2025Exercised options 2,962 shares of Day One Biopharmaceuticals, Inc.9
- Feb 18, 2025Sold 4,646 shares at $11.96 of Day One Biopharmaceuticals, Inc.10
- Feb 15, 2025Exercised options 3,687 shares of Day One Biopharmaceuticals, Inc.10
- Feb 15, 2025Exercised options 3,687 shares of Day One Biopharmaceuticals, Inc.10
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Jul 30, 2021 | BMY | Sale | $167.4K | −12.0% | +88.0% | −14.8% |
| May 5, 2021 | BMY | Sale | $200.3K | −7.6% | +93.3% | −18.4% |
| Nov 24, 2020 | BMY | Sale | $57.1K | −5.5% | +118.0% | +39.4% |
| May 22, 2020 | BMY | Sale | $195.2K | −1.7% | +162.9% | +31.2% |
| Dec 5, 2019 | BMY | Sale | $102.3K | +0.5% | +146.9% | +13.8% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Feb 18, 2026
- 7SEC EDGARForm 4 filed Nov 18, 2025
- 8SEC EDGARForm 4 filed Aug 19, 2025
- 9SEC EDGARForm 4 filed May 19, 2025
- 10SEC EDGARForm 4 filed Feb 21, 2025